![<![CDATA[Unpacking Advances Across Radiation Oncology From ASCO GU 2026]]>](https://images.sherpahealthy.com/qqQcU4Ov_aTefYbJj2UZdA-noPY=/filters:format(webp):max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pop/pop-cancernetwork-f7b5499f/1ea6ef4170f8dd5cb5359306eea076f2_wm.png)
<![CDATA[Unpacking Advances Across Radiation Oncology From ASCO GU 2026]]>
Summary: A digitally modified, meme-style collage of Dr. Brandon Mancini looking at his watch while a patient eats popcorn in front of a TV. Doctors thought pre-visit educational videos for prostate cancer would magically save consultation time. Plot twist: they don't speed things up, but patients do show up armed with way better questions.
Panel 2: Dr. Mancini holding a glowing "Pembrolizumab + Radiation" shield to block incoming cancer cells. High-risk localized prostate cancer meets the ultimate combo: immunotherapy plus radiation and androgen deprivation therapy (ADT). It’s safe, tolerable, and adding olaparib mostly just brings low-grade urinary annoyances rather than major high-grade drama.
Panel 3: A robot wearing a stethoscope reading clinical notes over Dr. Mancini's shoulder with the Golden Gate Bridge in the background. Large Language Models (LLMs) are now officially extracting and grading radiation toxicities directly from patient files. AI is capturing every last ounce of data so absolutely nothing slips through the cracks.
Panel 4: Dr. Mancini dropping a microphone shaped like a radiation symbol. Between AI workflow assistants and immunotherapy upgrades, genitourinary radiation oncology is getting a massive high-tech glow-up.
When AI reads your prostate radiation notes better than the medical resident. 🤖☢️